There are many causes that cause erectile dysfunction and there are also many treatments. Some oral drugs (Sildenafil, Tadalafil and Vardenafil) have achieved good therapeutic results but there are many patients for whom this medication is contraindicated or is ineffective.

EMDA, a non-invasive therapy capable of concentrating the drug in the appropriate place and amount, becomes a very attractive treatment for these patients who cannot be treated with oral drugs and want a minimally invasive method.

Clinical studies show that EMDA achieves positive results in patients suffering from impotence due to vascular insufficiency when Buflomedil, a vaso-active drug with dilating properties, is applied.

This therapeutic procedure is atraumatic, painless with an efficacy of impotence improvement of 3 to 6 months in 60% of patients (Bergamaschi F, Ordesi G, Corrada P, Torelli T, Zanitzer L, Campo B. Buflomedil transdermal electromotive administration (EMDA) in vasculogenic impotence: preliminary study. J. Urol 1996;155(5):744A.